These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 11834349)

  • 1. Temporal changes in myocardial endothelial nitric oxide synthase expression following human heart transplantation.
    Vejlstrup NG; Andersen CB; Boesgaard S; Mortensen SA; Aldershvile J
    J Heart Lung Transplant; 2002 Feb; 21(2):211-6. PubMed ID: 11834349
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of endomyocardial nitric oxide synthase and coronary endothelial function in human cardiac allografts.
    Wildhirt SM; Weis M; Schulze C; Conrad N; Pehlivanli S; Rieder G; Enders G; von Scheidt W; Reichart B
    Circulation; 2001 Sep; 104(12 Suppl 1):I336-43. PubMed ID: 11568079
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endothelium-smooth muscle interaction in cardiac transplantation.
    Skarsgard PL; McManus BM; van Breemen C; Laher I
    Clin Exp Pharmacol Physiol; 1998 Oct; 25(10):836-40. PubMed ID: 9784926
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of Celsior and University of Wisconsin preservation solutions on hemodynamics and endothelial function after cardiac transplantation in humans: a single-center, prospective, randomized trial.
    Wildhirt SM; Weis M; Schulze C; Conrad N; Rieder G; Enders G; Ihnken K; von Scheidt W; Reichart B
    Transpl Int; 2000; 13 Suppl 1():S203-11. PubMed ID: 11111997
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathogenetic mechanisms of cardiac allograft vasculopathy--impact of nitric oxide.
    Koglin J
    Z Kardiol; 2000; 89 Suppl 9():IX/24-7. PubMed ID: 11151787
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coronary flow reserve and nitric oxide synthases after cardiac transplantation in humans.
    Wildhirt SM; Weis M; Schulze C; Conrad N; Pehlivanli S; Rieder G; Enders G; von Scheidt W; Reichart B
    Eur J Cardiothorac Surg; 2001 Jun; 19(6):840-7. PubMed ID: 11404140
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased expression of constitutive nitric oxide synthase III, but not inducible nitric oxide synthase II, in human heart failure.
    Stein B; Eschenhagen T; Rüdiger J; Scholz H; Förstermann U; Gath I
    J Am Coll Cardiol; 1998 Nov; 32(5):1179-86. PubMed ID: 9809923
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of nitric oxide synthase in the human cardiac allograft is associated with contractile dysfunction of the left ventricle.
    Lewis NP; Tsao PS; Rickenbacher PR; Xue C; Johns RA; Haywood GA; von der Leyen H; Trindade PT; Cooke JP; Hunt SA; Billingham ME; Valantine HA; Fowler MB
    Circulation; 1996 Feb; 93(4):720-9. PubMed ID: 8641001
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nitric oxide synthase (NOS3) and contractile responsiveness to adrenergic and cholinergic agonists in the heart. Regulation of NOS3 transcription in vitro and in vivo by cyclic adenosine monophosphate in rat cardiac myocytes.
    Belhassen L; Kelly RA; Smith TW; Balligand JL
    J Clin Invest; 1996 Apr; 97(8):1908-15. PubMed ID: 8621775
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myocardial contractile effects of L-arginine in the human allograft.
    Paulus WJ; Kästner S; Vanderheyden M; Shah AM; Drexler H
    J Am Coll Cardiol; 1997 May; 29(6):1332-8. PubMed ID: 9137232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myocardial nitric oxide synthase gene-expression and endothelial function in chronic rejection after cardiac transplantation.
    Wildhirt SM; Weis M; Schulze C; Conrad N; Rieder G; Enders G; Meiser B; Kornberg A; Reichenspurner H; von Scheidt W; Reichart B
    Transplant Proc; 1999; 31(1-2):96-8. PubMed ID: 10083026
    [No Abstract]   [Full Text] [Related]  

  • 12. Anatomic distribution of nitric oxide synthase in the heart.
    Ursell PC; Mayes M
    Int J Cardiol; 1995 Jul; 50(3):217-23. PubMed ID: 8537144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Time course of coronary endothelial dysfunction in acute untreated rejection after heterotopic heart transplantation.
    Perrault LP; Bidouard JP; Janiak P; Villeneuve N; Bruneval P; Vilaine JP; Vanhoutte PM
    J Heart Lung Transplant; 1997 Jun; 16(6):643-57. PubMed ID: 9229295
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inducible nitric oxide synthase expression in smooth muscle cells and macrophages of human transplant coronary artery disease.
    Ravalli S; Albala A; Ming M; Szabolcs M; Barbone A; Michler RE; Cannon PJ
    Circulation; 1998 Jun; 97(23):2338-45. PubMed ID: 9639378
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ischaemia or reperfusion: which is a main trigger for changes in nitric oxide mRNA synthases expression?
    Pevni D; Frolkis I; Shapira I; Schwartz D; Schwartz IF; Chernichovski T; Lev-Ran O; Sharony R; Uretzky G
    Eur J Clin Invest; 2005 Sep; 35(9):546-50. PubMed ID: 16128860
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Profound inhibition of myogenic tone in rat cardiac allografts is due to eNOS- and iNOS-based nitric oxide and an intrinsic defect in vascular smooth muscle contraction.
    Skarsgard PL; Wang X; McDonald P; Lui AH; Lam EK; McManus BM; van Breemen C; Laher I
    Circulation; 2000 Mar; 101(11):1303-10. PubMed ID: 10725291
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Physical inactivity causes endothelial dysfunction in healthy young mice.
    Suvorava T; Lauer N; Kojda G
    J Am Coll Cardiol; 2004 Sep; 44(6):1320-7. PubMed ID: 15364339
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An association between microvascular endothelial dysfunction, transcardiac nitric oxide production and pro-inflammatory cytokines after heart transplantation in humans.
    Wildhirt SM; Weis M; Schulze C; Conrad N; Rieder G; Enders G; Hoepp C; von Scheidt W; Reichart B
    Transpl Int; 2000; 13 Suppl 1():S228-34. PubMed ID: 11112001
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liposome-mediated gene transfection of endothelial nitric oxide synthase reduces endothelial activation and leukocyte infiltration in transplanted hearts.
    Iwata A; Sai S; Nitta Y; Chen M; de Fries-Hallstrand R; Dalesandro J; Thomas R; Allen MD
    Circulation; 2001 Jun; 103(22):2753-9. PubMed ID: 11390348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The negative inotropic effect of beta3-adrenoceptor stimulation is mediated by activation of a nitric oxide synthase pathway in human ventricle.
    Gauthier C; Leblais V; Kobzik L; Trochu JN; Khandoudi N; Bril A; Balligand JL; Le Marec H
    J Clin Invest; 1998 Oct; 102(7):1377-84. PubMed ID: 9769330
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.